ASTHAstrana Health, Inc.

$38.12

The financials

Astrana Health, Inc. by the numbers

Astrana Health, Inc. (ASTH) reported revenue of $965M in Q1 2026 (quarter ended Mar 31, 2026), up 56% from the same quarter a year earlier. That came with a gross margin of 11% and net income of $14M (1.5% of revenue). For the full year FY2025, revenue was $3.18B (+56% year on year) and net income $22M. Its largest product in Jun 2026 was Health Care Capitation at $906M, 93% of the disclosed total, well ahead of Health Care Patient Service at 2.4%.

Astrana Health, Inc. income statement, Q1 2026 against the same quarter a year earlier
Income statementQ1 2026Q1 2025Change
Revenue$965M$620M+56%
Gross profit$106M$71M+48%
Operating income$29M$21M+39%
Net income$14M$6.7M+116%
Diluted EPS$0.29$0.14+107%
Revenue by product, Jun 2026, as reported to the SEC
ProductRevenueShare
Health Care Capitation$906M93%
Health Care Patient Service$23M2.4%
Health Care Other$22M2.2%
Management Service$13M1.4%
Product And Service Other$8.7M0.9%

Business Segments

Revenue split by product segment, from SEC XBRL filings.

Latest period: Jun 2026Total $972.5M (+0.77%)
Management Service grew +413% year on yearHealth Care Patient Service +29% year on year
  • Health Care Capitation$905.8MQoQ +1.4%year on year +47%
  • Health Care Patient Service$23.0MQoQ -39%year on year +29%
  • Health Care Other$21.8MQoQ +75%year on year +42%
  • Management Service$13.2MQoQ -16%year on year +413%
  • Product And Service Other$8.7MQoQ +41%year on year +80%
Segment sum = 100% of reported consolidated revenue · Latest source: 10-Q filed 2026-08-10, SEC EDGAR